American Well Corporation

NYSE AMWL

American Well Corporation Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2024: USD -14.12 M

American Well Corporation Capital Expenditure is USD -14.12 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 42.07% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

American Well Corporation Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -24.38 M.
American Well Corporation Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2020 was USD -3.50 M.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

NYSE: AMWL

American Well Corporation

CEO	Dr. Ido Schoenberg M.D.
IPO Date	Sept. 17, 2020
Location	United States
Headquarters	75 State Street
Employees	1,104
Sector	Health Care
Industries Telehealth

Description

American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Key trends

Past 5 years